DARPA recently spent millions on research involving bats and coronaviruses, as well as gene editing “bioweapons” prior to the recent coronavirus outbreak. Now, “strategic allies” of the agency have been chosen to develop a genetic material-based vaccine to halt the potential epidemic. By Whitney Webb | The Last American Vagabond | January 30, 2020 WASHINGTON […]
Source